Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
24,189,141
-
Total 13F shares
-
635,473
-
Share change
-
+29,257
-
Total reported value
-
$947,155
-
Put/Call ratio
-
52%
-
Price per share
-
$1.49
-
Number of holders
-
27
-
Value change
-
-$78,728
-
Number of buys
-
11
-
Number of sells
-
11
Institutional Holders of Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR) as of Q1 2025
As of 31 Mar 2025,
Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
635,473 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., UBS Group AG, Squarepoint Ops LLC, STATE STREET CORP, NORTHERN TRUST CORP, Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors, Arkadios Wealth Advisors, and IFP Advisors, Inc.
This page lists
27
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.